Coming Soon...

Graduated in Molecular Biology (PhD) and Finance (MBA). Headed Regulatory and Medical Affairs for Pharmaco (NZ) Ltd, representing 20 international pharma companies, primarily at Rx level. In 2005, moved to the UK as International Head, Health, Safety and Environment for Reckitt Benckiser, then to Switzerland as VP/Head International Regulatory Affairs, Bayer Consumer Care, AG. Currently Team Leader Special Projects, Region Europe at BCC AG, Switzerland.

After initial training in General Obstetrics and Gynaecology at Southampton University, UK, Professor Jenkins gained further specialist infertility experience while working on the university in vitro fertilization programme. Following specialist training in reproductive medicine at Sheffield University, he became Consultant Senior Lecturer in Reproductive Medicine in the Centre for Reproductive Medicine at the University of Bristol. As the Clinical Director at this centre from 1999 to 2006, his research interests included reproductive medicine and pioneering work in medical informatics. This work led to multiple presentations, 4 books, 14 book chapters and over 100 articles. During this time he sat on various committees, including a large research ethics committee and launched a highly successful world renowned MSc course in reproduction and development delivered principally over the Internet.

Professor Jenkins has held positions in many professional bodies, including chairing the European Society of Human Reproduction and Embryology Classification of Infertility Taskforce and the British Fertility Society website editorial board. He has also been a member of the editorial boards for Human Reproduction and BJOG: An International Journal of Obstetrics and Gynaecology. Prior to joining Ferring Pharmaceuticals in January 2009, Professor Jenkins was Senior Medical Director in Endocrinology and Reproductive Health, at Merck Serono International S.A. and currently holds a visiting professorship at the University of Warwick, UK. Initially appointed within Ferring as Global Medical Affairs Director in Reproductive Health from Jan 2009 he was promoted to head the Global Medical Affairs group in July

Simon Freedman is currently Vice President of Marketing EAME for Torax Medical, he has been in this role for since November 2010 and is responsible for the commercialisation of a novel medical device for the treatment of reflux disease. Prior to this, Simon spent 9 years at Allergan, launching the post-stroke spasticity indication for Botox Neuroscience and Botox Cosmetic across Europe, latterly Simon spent 3 years leading the development of Allergan's gastric band and gastric balloon weight loss business. Simon has around 20 years experience in pharmaceutical and medical device sales and marketing working across a diverse range of indications and products

Shaul Brazil is a barrister with BCL Burton Copeland solicitors in London, specialising in business crime and regulation. He has particular experience in serious fraud, overseas corruption and contentious financial services regulation. His practice also encompasses cartel defence, extradition and mutual legal assistance, money laundering and all matters relating to the proceeds of crime.

Shaul has acted in numerous high profile proceedings brought by agencies such as the Serious Fraud Office, the Financial Services Authority, and the US Department of Justice. Recent cases include acting for a former director of a large engineering company in relation to an overseas corruption and breach of sanctions against Iraq prosecution, acting for a former director of a multinational healthcare company in relation to an overseas corruption prosecution, acting for a fund of funds in relation to investigations arising from the collapse of Bernard L Madoff Investment Securities LLC, and acting for a former senior manager in a price-fixing prosecution by the US Department of Justice.

Kevin Appareti is Global Director, Medical Science Liaison for the Office of Medical and Health Affairs (OMAHA) at Philips Healthcare. He is responsible for managing the Key Opinion Leader (KOL) Management Program to deliver Strategic Guidance, Leverage Clinical and Scientific Knowledge, Foster Peer-to-Peer Relationships, and support Clinical and Marketing Evidence Development.

Previously, Kevin was Senior Marketing Manager, Global Luminary Management, for Philips Healthcare's Ultrasound business. Before that, he was Worldwide Market Development Manager and Director of Product Marketing for Ultrasound and has held positions in Marketing Management for Professional Services, Information Technologies, and Clinical Marketing. Kevin began his career as Program Director for the Diagnostic Medical Sonography Training Program at the University of Colorado Health Sciences Center in Denver, while participating in clinical research.

Kevin has a BS in Physical Science from Colorado State University, and an MBA from Boston University. He also is an Adjunct Professor at the University of Massachusetts, where he develops curriculum and lecturing materials for an Organizational Behavior course in the MBA program in the College of Management. He is based in Andover, Massachusetts.

Michael Uecker is presently Senior Manager Medical Science Liaison at ALK-Abelló in Wedel, Germany. He is responsible for developing, establishing and fostering collaborative relationships to Key Opinion Leaders. He holds a M.Sc. in Pharmacy and was previously working as International Product Manager in Denmark, Head of Pharmacovigilance, and Medical Advisor. Michael is certified in Pharmaceutical Medicine (Zert. Pharm. Med. -DGPharMed-) and Member of Deutsche Gesellschaft fŸr Pharmazeutische Medizin and Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI).

Currently Director of Medical affairs at Baxter Healthcare. An international business professional with a proven track record in achieving communication objectives and commercial targets in the multinational Pharmaceutical and Medical Device Industry.

Previously International Senior Product Manager at Astrellas pharma.Driving Astellas' B2B and B2C transplantation and anti-infective business in 23 markets in Central and Eastern Europe, Middle East and Africa comprising business development, sales and operational and strategic marketing including brand planning and forecasting.

Susanna Palkonen works as the Executive Officer of European Federation of Allergy and Airways Diseases Patients' Associations (EFA) and is Vice President of the European Patients' Forum EPF. She has been involved in the patient movement for over 15 years. She is a member of the EU Consultative Forum on Environment and Health of the European Commission Directorate General (DG) Environment and DG Health and Consumers (SANCO) Indoor Air Quality Expert Group and represents EPF in the European Medicines Agency (EMA) Working Group with Patient and Consumer organisations. She is also a member of the User Advisory Board of the Renewing Health project from the EC ICT Policy Support Programme, Advisory Group of the Integrated Exposure for Risk Assessment in indoor environments (INTERA) and Schools Indoor Pollution and Health: Observatory Network in Europe (SINPHONIE) project , Allergic Rhinitis and Its' Impact of Asthma (ARIA) Initiative Guidelines Advisory Committee, the Editorial Board of the Italian Journal of Primary Care and Scientific Committee of the 19th International Conference on Health Promoting Hospitals and Services among others.

Being a patient with allergic rhinitis and atopic eczema herself, her special interests are prevention, environment and health from the patients' perspective. As a patient representative, Susanna has also co-authored several papers on various aspects of managing and overcoming allergy and asthma.

Coming Soon...

Keith Allan is currently Head of Global Product Advocacy for Novartis based in Basel, Switzerland. This position is aligned to the Market Access needs for Novartis products, and is involved in creating sustainable partnerships with influential stakeholders - particularly academic/scientific groups, KOLs, patient organisations and regulatory advisors. He joined Novartis in 2000 as Head of Global Respiratory Marketing.

He was previously Global Marketing Director for Aventis Respiratory and Allergy Portfolio (formerly Rhone-Poulenc Rorer), based their Corporate Headquarters in Paris, France.

Originally a Graduate Microbiologist/Biochemist, working in medical research, he started his pharmaceutical industry career with Hoechst as a Medical Representative in the UK, before moving to Fisons Pharmaceuticals also as a Medical Representative, Sales Trainer and Area Sales Manager. His marketing career started with Fisons as a Brand Manager for Intal in the UK before moving to Merck (MSD) where he was their UK Marketing Manager for 5 years, also involved in Business Development activities. He re-joined Fisons in 1986, where after a period in Global Strategic Marketing, he was appointed Marketing and Sales Director for Fisons France, for 3 years just prior the RPR acquisition of Fisons. Following the acquisition in 1995, he was appointed to Global Marketing Director, a position he held until after the merger with HMR to form Aventis in 1999.

Coming Soon...

Dr Erwin MEIJER works for Nutricia Advanced Medical Nutrition (a specialised healthcare division of Danone), in the role of Medical Affairs Knowledge Manager. Erwin is responsible for developing the division's educational strategy, internally and externally, to leverage the science of medical nutrition. Execution of a broad and effective stakeholder engagement strategy is integral to achieving this goal.

Erwin joined Nutricia in 2001 as a Research Scientist at the Nutricia R&D centre in Wageningen, The Netherlands. In 2004, he was appointed Senior Scientist and R&D Project Leader on disease-targeted nutrition concepts for COPD and Decubitus. In 2009, he was assigned to Danone Research in Palaiseau (France), where he was responsible for scientific validation of communication and health claims for the brand Activia.

Nutricia Advanced Medical Nutrition has a mission to lead the use of specialised nutrition in disease management. With its focus on science-based nutrition delivering proven consumer benefits and better clinical outcomes for patients, Nutricia supports Danone's broader mission to bring health through food to as many people as possible. In more than 50 countries, Nutricia supports carers and healthcare professionals in improving the lives of both paediatric and elderly patients, with a brand family including Nutrison, Fortisip, Nutrini and Neocate

Dr. Samuel Dyer is a dynamic skilled Medical Affairs professional with over 10 years experience within International Medical Affairs for a number of companies. During his career, he has led MSL / Medical Teams in multiple TA’s in over 60 countries throughout the U.S., Canada, Europe, Africa, Middle East, New Zealand and Australia. His management experience includes small (2+) to large (240+) medical teams across multiple TA’s. Throughout his career, Dr. Dyer has worked on MSL and Medical strategy and has extensive experience in creating strategic MSL utilization and medical communication plans. He has designed, and created global MSL programs that have included: strategic assessments, planning, and execution in geographical locations with diverse cultures/languages. Dr. Dyer has also worked on numerous clinical trials, KOL Investigator Sponsored Trials, and has been involved in the successful launch of both pharmaceutical and medical device products both in the U.S. and internationally.

Over the years Dr. Dyer has developed an extensive international network within the Pharmaceutical, CRO, Medical Device, and Medical Communication industries. He has been an invited speaker at several conferences on various topics including creating MSL teams, international MSL teams, and the value of the MSL role. He has also worked as a consultant with a number of companies for Medical Affairs projects including recently with McKinsey Consulting and Bain and Co.

Dr. Dyer has a B.S. in Biology and did his Medical training in Chicago. He has a Master’s Degree in Tropical Biology (where he studied in the Amazon) and a Ph.D. in Medical Science. Dr. Dyer also completed a certificate program at Harvard Business School, for Executive Leadership and Strategy in Pharmaceuticals and Biotechnology.

Dr. Dyer currently sits on the management team /board of advisors for the start up Biotech company-Biognosys. He is also the author of a first of its kind book on the MSL role that is expected to be published in the Spring of next year. Dr. Dyer is the CEO/founder and currently manages, with a team of professionals, www.MSLWORLD.com the industry’s first and only comprehensive interactive career management site 100% dedicated, focused and built to serve the Medical Science Liaison (MSL) career.

Coming Soon...

Coming Soon...

Bertalan Mesko, MD graduated from the University of Debrecen, Medical School and Health Science center in 2009 and started PhD in the field of clinical genomics. He is the managing director and founder of Webicina.com LLC, the first free medical social media guidance service for patients and medical professionals. He speaks at prestigious conferences; covers online international events and is a health 2.0 consultant for pharma and medical companies. Healthspottr.com included him in the Future Health Top 100 list.

He is the author of the award-winning medical blog, Scienceroll.com and the educator of the Medicine and Web 2.0 university credit course which is the first of its kind worldwide.

He was mentioned in Nature Medicine, the New York Times, Al Jazeera, British Medical Journal and Wired Science, among others. He is a member of the Kairos Society.

Coming Soon...

Hervé DREVOT is vice-president of CrossWorlds HealthCare Professionals. CWHCP is pan-European Think Tank made of clinical and non-clinical thought leaders who aspire to positively transform the health ecosystems.

In 2010-11, CWHCP sponsored an independent in-depth research at pan-European level to identify best practices and key opportunities for collaboration throughout the entire health value chain, with the ultimate objective to improve the benefits for the patient and increase healthcare system efficiency. Research has been conducted under the guidance of internationally renowned medical experts. Results are derived from over 100 face to face interviews with key constituents of the health ecosystems including patient groups, health care providers, policy makers and regulators.

Hervé started career at Deloitte in 1987. He held leading positions in several consultancies before he co-founded StarGen. StarGen is a strategy consultancy serving health and life sciences organizations to transform their value proposition and their collaborations to create lasting competitive advantages.

In the recent years Hervé has been involved in the orchestration and delivery of collaborative initiatives involving tier-one medical experts, scientific societies, Industry and other stakeholders at pan-European level in different therapeutic areas. These initiatives aim to accelerate translation of guidelines into practical medical practice, improve patient outcomes, develop care efficiency, generate data to support innovation, continuous improvement and health-economic decisions.

More generally, he has gained an extended experience with Health Care and Life Sciences industries through a broad range of complex engagements (Strategic assessments, brand planning, competitive war gaming, advocacy strategy, Alliance, commercial excellence, organizational capability development) for major players across Europe, USA and Japan.

Coming Soon...

Heather Simmonds is the Executive Director of ABPI. Heather chairs the Code of Practice Panel for PMCPA, which considers complaints submitted under the Code in the first instance, and is responsible for the overall running of the organisation. Heather also works with IFPMA and EFPIA in relation to their codes of practice.

Heather has a degree in pharmacology and joined the ABPI in 1984. Heather has been working full time on the Code of Practice since 1989 and has been Director of the Authority since 1997.

Coming Soon...

Coming Soon...